Fit 01
Seed → Series B Biotech
You've raised institutional capital, you have real science, and you need to convert it into the next round, partnership or commercial milestone within 12–18 months.
Home / About
ManifestoWhy we exist
We exist because brilliant biotech is invisible biotech.
A scientist with a breakthrough therapy shouldn't lose a Series A to a competitor with a louder LinkedIn presence. But it happens every quarter. That's the problem we built Bioverse to solve.
01The origin
Built by people who watched great science die quietly.
Bioverse was founded because we kept seeing the same story: a brilliant biotech founder, a real scientific breakthrough, and a fundraising round that fell apart because the wrong investors heard about it too late.
Meanwhile, a generic competitor with mid-tier science but excellent positioning closed the round.
The biotech ecosystem rewards the visible, not always the brilliant. We exist to make sure the brilliant become the visible.
This isn't a marketing problem. It's a survival problem.
02How we're different
We don't take generalist clients. Ever.
Most agencies say they specialise in everything. We mean it: we only work with biotech, life sciences and healthcare innovators. That's why we speak the language of your investors, partners and KOLs without translation.
- P.01
Biotech-only, always
We turn down B2B SaaS, e-commerce and consumer brands every week. Our entire workflow, vocabulary and team is engineered for life sciences. No translation tax.
- P.02
Productized, not vague
Every service has defined inputs, outputs and timelines. You know exactly what you're paying for. No "discovery phases" that consume budget without producing assets.
- P.03
Outcomes over activity
We measure investor inbounds, partnership conversations and talent applications. Not impressions, not vanity metrics: the numbers your board actually cares about.
- P.04
Founder-first voice
Your founder is the brand. We protect their voice, their scientific integrity and their time, and write what they would write if they had eight more hours each week.
- P.05
AI-search native
While other agencies still optimise for Google 2018, we optimise for ChatGPT, Perplexity and Google AI Overviews, where the next five years of investor research happens.
- P.06
Compounding assets
Every post, page and paper we ship makes the next one work harder. Authority compounds. Visibility compounds. Investor trust compounds. That's the entire game.
03Who we work with
Funded biotech founders who refuse to stay invisible.
We're selective. If you fit one of these profiles, we'd love to talk. If you don't, we'll happily refer you elsewhere.
Fit 02
Diagnostics & Devices
You sell into clinicians, hospitals or labs. Your buyers are highly technical and your sales cycle is long. You need authority assets that compound trust over months.
Fit 03
Tools, Platforms & CROs
You serve other biotech and pharma companies. Your buyers research extensively before they ever take a call. You need to be the first name they encounter.
Let's talk
Find out if we're the right partner, in 30 minutes.
No pitch deck. No sales pressure. Just a candid conversation about your stage, your goals, and whether Bioverse is the right fit. We'll tell you honestly either way.